POWER3 CONVERTS PROVISIONAL PATENT APPLICATIONS

Power3 Medical Products announced today that it has converted two provisional patent applications by the filing of two utility patent applications with the United States Patent and Trademark Office for the Company's disease specific biomarker discovery and disease specific immuno-diagnostic test designs. These patent applications are being filed to protect Power3 Medical's proprietary platform technologies that the Company is using in conjunction with major research institutions in the Houston area, to develop disease specific diagnostic tests for neurodegenerative disease, breast cancer, and drug resistance. These applications are two of 9 utility patents pending, 12 provisional patent applications, and 1 issued patent, owned and/or licensed by Power3.

News-Medical.net (http://www.news-medical.net/?id=12278)